Skip to content

FP7H2020HORIZON

H. Lundbeck As

Country
DKDenmark
Projects
42
As coordinator
2
EU contribution (CORDIS)
EUR 1,934,621
Active
2008 to 2026

Projects

42 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
LIPAGGFrom biophysical chemistry to cell biology: Deciphering the role of lipids in the toxicity and spreading of protein aggregationHORIZON2026Associated partnerNot stated
BICEPSBeyond neuroInflammation: new Concepts to Elucidate the immune system’s vital role in Parkinson’s diseaseHORIZON2024ParticipantEUR 301,788
NHPigReducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig ModelsHORIZON2024ParticipantEUR 0
Syn2PsySynaptic Dysfunction in Neuropsychiatric DisordersH20202019ParticipantEUR 297,522
EBiSC2EBiSC2 – A sustainable European Bank for induced pluripotent Stem CellsH20202019ParticipantEUR 0
IM2PACTInvestigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The BrainH20202019ParticipantEUR 0
PD-MitoQUANTPD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's diseaseH20202019ParticipantEUR 0
PET-AlphaSyPET Imaging of Alpha-Synuclein Fibril FormationH20202018PartnerEUR 0
PARADIGMPatients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.H20202018ParticipantEUR 0
EHDENEuropean Health Data and Evidence NetworkH20202018ParticipantEUR 0
SYNDEGENSynaptic dysfunction in Neurodegenerative DiseasesH20202017PartnerEUR 0
IMPRiNDInhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060H20202017ParticipantEUR 0
TreatERClinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug deliveryH20202017ParticipantEUR 48,750
COSYNComorbidity and Synapse Biology in Clinically Overlapping Psychiatric DisordersH20202016ParticipantEUR 75,000
PEARRLPharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicinesH20202016ParticipantEUR 0
EU-GliaPhDTraining, Research and Raising of Public Awareness in Cell Biology and Pathology of NeurogliaH20202016ParticipantEUR 290,082
RADAR-CNSRemote Assessment of Disease and Relapse in Central Nervous System DisordersH20202016ParticipantEUR 0
PHAGOInflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976H20202016ParticipantEUR 0
ROADMAPReal world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020H20202016ParticipantEUR 0
EPADEuropean Prevention of Alzheimer’s Dementia ConsortiumFP72015ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC). A body with sites in several countries is recorded under one of them, which is not always its legal seat: the Spanish research council CSIC, for example, appears under Italy. The data holds no country per site, so we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.